|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:bfsLayer
|
3
|
|
gptkbp:bfsParent
|
gptkb:Sanofi
gptkb:Aventis
|
|
gptkbp:acquired
|
gptkb:Sanofi
|
|
gptkbp:acquisition
|
gptkb:2011
Genzyme Corporation by Sanofi in 2011
|
|
gptkbp:awards
|
recognized for innovation in biotechnology
won awards for workplace culture
received accolades for patient care initiatives
|
|
gptkbp:ceo
|
gptkb:David_Meeker
|
|
gptkbp:clinical_trial
|
conducts clinical trials for new therapies
|
|
gptkbp:community_involvement
|
engages in corporate social responsibility initiatives
supports patient advocacy groups
|
|
gptkbp:employees
|
over 10,000
|
|
gptkbp:focus
|
gptkb:healthcare_organization
gptkb:psychologist
metabolic disorders
neurology
rare diseases
hematology
orthopedics
immunology
|
|
gptkbp:focus_area
|
gptkb:physicist
gptkb:drug
sustainable practices
personalized medicine
clinical research
biologics
therapeutics
healthcare solutions
patient support programs
diagnostics
biomanufacturing
|
|
gptkbp:founded
|
gptkb:1981
|
|
gptkbp:founder
|
gptkb:Henri_Termeer
|
|
gptkbp:headcount
|
approximately 10,000 employees globally
|
|
gptkbp:headquarters
|
gptkb:Cambridge,_Massachusetts
gptkb:Cambridge,_MA,_USA
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Genzyme
|
|
gptkbp:industry
|
gptkb:Company
|
|
gptkbp:market
|
global presence in over 35 countries
|
|
gptkbp:parent_company
|
gptkb:Sanofi
|
|
gptkbp:part_of
|
gptkb:Sanofi_Group
|
|
gptkbp:partnerships
|
collaborations with academic institutions
alliances with other biotech companies
|
|
gptkbp:products
|
gptkb:Cerezyme
gptkb:Fabrazyme
gptkb:Myozyme
gptkb:Synvisc
gptkb:Thyrogen
|
|
gptkbp:regulatory_compliance
|
FDA approved products
|
|
gptkbp:research_and_development
|
focus on rare genetic diseases
|
|
gptkbp:revenue
|
$4.5 billion (2014)
|
|
gptkbp:services
|
genetic testing
biopharmaceuticals
|
|
gptkbp:subsidiary
|
gptkb:Genzyme_Genetics
gptkb:Genzyme_Biosurgery
gptkb:Genzyme_Pharmaceuticals
|
|
gptkbp:website
|
www.genzyme.com
|